Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
EMINENCE CAPITAL, LP GTBIF Green Thumb Industries Inc. 13G/A 3.6% 6mo
VAN ECK ASSOCIATES CORP UUUU Energy Fuels Inc 13G/A 6.48% 6mo
CastleKnight Master Fund LP CYH Community Health Systems Inc 13G/A 9% 6mo
ARMISTICE CAPITAL, LLC AUTL Autolus Therapeutics plc 13G/A 5.94% 6mo
T. Rowe Price Investment Management, Inc. CVLG Covenant Logistics Group, Inc. 13G 5.2% 6mo
Fort Baker Capital Management LP FTW PRESIDIO PRODUCTION Co 13G/A 2.8% 6mo
ARMISTICE CAPITAL, LLC TMCI Treace Medical Concepts, Inc. 13G/A 9.85% 6mo
Nextech Crossover I GP S.a. r.l. TNGX Tango Therapeutics, Inc. 13G/A 5.1% 6mo
BAKER BROS. ADVISORS LP KALA KALA BIO, Inc. 13G/A 0.01% 6mo
Kerry Propper CAPN Cayson Acquisition Corp 13G/A 0% 6mo
Encompass Capital Advisors LLC SEI Solaris Energy Infrastructure, Inc. 13G/A 3.01% 6mo
CITADEL ADVISORS LLC SPRB Spruce Biosciences, Inc. 13G/A 5.1% 6mo
METEORA CAPITAL, LLC CRAQ Cal Redwood Acquisition Corp. 13G/A 9.58% 6mo
BAKER BROS. ADVISORS LP GLUE Monte Rosa Therapeutics, Inc. 13G/A 9.99% 6mo
Graham Holdings Co PUBM PubMatic, Inc. 13G/A 8.9% 6mo
Point72 Asset Management, L.P. EDSA Edesa Biotech, Inc. 13G/A 0% 6mo
Alyeska Investment Group, L.P. BBCQ Bleichroeder Acquisition Corp. II 13G 5.54% 6mo
Kenneth Griffin MED Medifast Inc 13G 6.5% 6mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC ELMES Elme Communities 13G/A 8.4% 6mo
RTW INVESTMENTS, LP RAPT RAPT Therapeutics, Inc. Common Stock 13G/A 0% 6mo
CANNELL CAPITAL LLC GLXZ Galaxy Gaming, Inc. 13G 5.2% 6mo
Caligan Partners LP IRD Opus Genetics, Inc. 13G 8.5% 6mo
ARMISTICE CAPITAL, LLC ASTI Ascent Solar Technologies, Inc. 13G/A 4.99% 6mo
Anson Funds Management LP MCGA Yorkville Acquisition Corp. 13G/A 0% 6mo
LAZARD ASSET MANAGEMENT LLC IIF Morgan Stanley India Investment Fund, Inc. 13G 6.5% 6mo
WELLINGTON MANAGEMENT GROUP LLP IDA Idacorp Inc 13G/A 5.2% 6mo
Orbis Investment Management Limited CRSP CRISPR Therapeutics AG 13G/A 6.3% 6mo
COHEN & STEERS, INC. KIM Kimco Realty Corp 13G/A 7.93% 6mo
COHEN & STEERS, INC. NTST NETSTREIT Corp. 13G/A 14% 6mo
Qube Research & Technologies Ltd SLMT Solmate Infrastructure PLC 13G/A 3.6% 6mo
Two Seas Capital LP MDRX Veradigm Inc. Common Stock 13G/A 8.2% 6mo
T. Rowe Price Investment Management, Inc. MANH Manhattan Associates Inc 13G 5.9% 6mo
PAULSON & CO. INC. MDGL Madrigal Pharmaceuticals, Inc. 13G/A 6.1% 6mo
EVENTIDE ASSET MANAGEMENT, LLC COLL Collegium Pharmaceutical, Inc 13G/A 4.5% 6mo
TORONTO DOMINION BANK IMTX Immatics N.V. 13G 5.5% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ SARO StandardAero, Inc. 13G/A 11.7% 6mo
PERCEPTIVE ADVISORS LLC TRAW Traws Pharma, Inc. 13G/A 6.1% 6mo
Vestal Point Capital, LP APRE Aprea Therapeutics, Inc. 13G 9.9% 6mo
Point72 Asset Management, L.P. PTN Palatin Technologies Inc 13G/A 0.5% 6mo
EARNEST PARTNERS LLC GATX Gatx Corp 13G/A 7.3% 6mo
CITADEL ADVISORS LLC ASST Strive, Inc. 13G/A 5.2% 6mo
Soroban Capital Partners LP DPZ Dominos Pizza Inc 13G 7.4% 6mo
Lawrence M. Blatt, Ph.D. ALGS Aligos Therapeutics, Inc. 13G 5.1% 6mo
SB INVESTMENT ADVISERS (UK) LTD NRGV Energy Vault Holdings, Inc. 13G/A 8.9% 6mo
Rubric Capital Management LP CVGW Calavo Growers Inc 13G 7.93% 6mo
Khrom Investments Fund, LP ACHC Acadia Healthcare Company, Inc. 13G/A 5.66% 6mo
WELLINGTON MANAGEMENT GROUP LLP RUSHA Rush Enterprises Inc Tx 13G/A 4% 6mo
Point72 Asset Management, L.P. DSGN Design Therapeutics, Inc. 13G/A 4.4% 6mo
Anson Funds Management LP NRXP NRX Pharmaceuticals, Inc. 13G/A 4.9% 6mo
CITADEL ADVISORS LLC DPRO Draganfly Inc. 13G/A 5.3% 6mo